Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 70505-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 70505-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Analog Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)
Each tablet contains Donfanine Succivate and yidone Hyocloide. It's a delayed-release tablet and recommended dosage is one of four tablets daily. It should be stored at a temperature between 20°C to 26°C (68°F to 77°F) with excursions permitted between 16°C and 30°C (50°F and 86°F). It also has a warning to swallow the tablet whole. The given information is related to a medication with the product name W70505-100-10 and contains 100 delayed-release tablets. The provided NDC code "70505-100-10" refers to drug product "ANALOG", and it's available by a prescription only. The text does not provide any information about what the medication is used for or its potential side effects.*
FDA Label Image

Bottle Label – Inside Cover (Bottle Label Inside)

Bottle Label – Inside Cover (Bottle Label Inside)
This is a medication packaging for Doxylamine Succinate and Pyridoxin Hydrochloride. The storage instructions indicate that it should be stored at room temperature, and out of reach of children. The medication is a delayed-release tablet and should be swallowed whole without crushing or chewing. The package contains 100 tablets. For further information, healthcare professionals can request product information from Analog Pharma.*
FDA Label Image

Structure-1 (Structure 1)

FDA Label Image

Structure-2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.